Sequential changes of Legionella antigens and bacterial load in the lungs and urines of a mouse model of pneumonia

Diagnostic Microbiology and Infectious Disease

Volumn 66, Issue 3, 2010, Pages 253-260

  Chen, Yu ^a,b,c   Tateda, Kazuhiro ^a   Fujita, Kazue ^a,b   Ishii, Toshiaki ^a   Ishii, Yoshikazu ^a   Kimura, Soichiro ^a   Saga, Tomoo ^a   Annaka, Toshimitsu ^d   Yamada, Shingo ^e   Zhao, Li ^c   Li, Shengqi ^c   Azuma, Arata ^b   Gemma, Akihiko ^b   Kudoh, Shoji ^b   Yamaguchi, Keizo ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

^c CHINA MEDICAL UNIVERSITY   (China)

^d EIKEN CHEMICAL CO LTD   (Japan)

^e SHINO TEST CORPORATION   (Japan)

Author keywords

Antigen; HMGB1; LAMP; Legionella pneumophila

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL DNA; CYTOKINE; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; DNA EXTRACTION; FEMALE; LEGIONELLA PNEUMOPHILA; LIVER; LUNG HOMOGENATE; LUNG LAVAGE; MOUSE; NONHUMAN; PNEUMONIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; URINALYSIS;

ANIMALS; ANTIGENS, BACTERIAL; BRONCHOALVEOLAR LAVAGE FLUID; COLONY COUNT, MICROBIAL; CYTOKINES; DISEASE MODELS, ANIMAL; DNA, BACTERIAL; FEMALE; HMGB1 PROTEIN; LEGIONELLA PNEUMOPHILA; LEGIONNAIRES' DISEASE; LIVER; LUNG; MICE; MICE, INBRED A; POLYMERASE CHAIN REACTION; URINE;

EID: 77349094766     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2009.11.001     Document Type: Article

References (35)

1. Alleva L.M., Budd A.C., Clark I.A. Systemic release of high mobility group box 1 protein during severe murine influenza. J. Immunol. 2008, 181:1454-1459.
2. Bianchi M.E., Manfredi A.A. High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunol. Rev. 2007, 220:35-46.
3. Breiman R.F., Butler J.C. Legionnaires' disease: clinical, epidemiological, and public health perspectives. Semin. Respir. Infect. 1998, 13:84-89.
4. Brieland J.K., Remick D.G., Freeman P.T., Hurley M.C., Fantone J.C., Engleberg N.C. In vivo regulation of replicative Legionella pneumophila lung infection by endogenous tumor necrosis factor alpha and nitric oxide. Infect. Immun. 1995, 63:3253-3258.
5. Byrne B., Swanson M.S. Expression of Legionella pneumophila virulence traits in response to growth conditions. Infect. Immun. 1998, 66:3029-3034.
6. Couch R.B. The effects of influenza on host defenses. J. Infect. Dis. 1981, 144:284-291.
7. Diederen B.M. Legionella spp. and Legionnaires' disease. J. Infect. 2008, 56:1-12.
8. Dominguez J.A., Gali N., Pedroso P., Fargas A., Padilla E., Manterola J.M., Matas L. Comparison of the Binax Legionella urinary antigen enzyme immunoassay (EIA) with the Biotest Legionella Urin antigen EIA for detection of Legionella antigen in both concentrated and nonconcentrated urine samples. J. Clin. Microbiol. 1998, 36:2718-2722.
9. el-Ebiary M., Sarmiento X., Torres A., Nogue S., Mesalles E., Bodi M., Almirall J. Prognostic factors of severe Legionella pneumonia requiring admission to ICU. Am. J. Respir. Crit. Care Med. 1997, 156:1467-1472.
10. Fernandez-Serrano S., Dorca J., Coromines M., Carratala J., Gudiol F., Manresa F. Molecular inflammatory responses measured in blood of patients with severe community-acquired pneumonia. Clin. Diagn. Lab. Immunol. 2003, 10:813-820.
11. Fields B.S., Benson R.F., Besser R.E. Legionella and Legionnaires' disease: 25 years of investigation. Clin. Microbiol. Rev. 2002, 15:506-526.
12. Furugen M., Higa F., Hibiya K., Teruya H., Akamine M., Haranaga S., Yara S., Koide M., Tateyama M., Mori N., Fujita J. Legionella pneumophila infection induces programmed cell death, caspase activation, and release of high-mobility group box 1 protein in A549 alveolar epithelial cells: inhibition by methyl prednisolone. Respir. Res. 2008, 9:39.
13. Gebran S.J., Newton C., Yamamoto Y., Widen R., Klein T.W., Friedman H. Macrophage permissiveness for Legionella pneumophila growth modulated by iron. Infect. Immun. 1994, 62:564-568.
14. Grover A., Taylor J., Troudt J., Keyser A., Sommersted K., Schenkel A., Izzo A.A. Mycobacterial infection induces the secretion of high-mobility group box 1 protein. Cell. Microbiol. 2008, 10:1390-1404.
15. Gump D.W., Frank R.O., Winn W.C., Foster R.S., Broome C.V., Cherry W.B. Legionnaires' disease in patients with associated serious disease. Ann. Intern. Med. 1979, 90:538-542.
16. Kohler R.B., Winn W.C., Wheat L.J. Onset and duration of urinary antigen excretion in Legionnaires disease. J. Clin. Microbiol. 1984, 20:605-607.
17. Kragsbjerg P., Jones I., Vikerfors T., Holmberg H. Diagnostic value of blood cytokine concentrations in acute pneumonia. Thorax 1995, 50:1253-1257.
18. Le Roux C.A., Kubo T., Grobbelaar A.A., van Vuren P.J., Weyer J., Nel L.H., Swanepoel R., Morita K., Paweska J.T. Development and evaluation of a real-time reverse transcription-loop-mediated isothermal amplification assay for rapid detection of Rift Valley fever virus in clinical specimens. J. Clin. Microbiol. 2009, 47:645-651.
19. Lieberman D., Porath A., Schlaeffer F., Boldur I. Legionella species community-acquired pneumonia. A review of 56 hospitalized adult patients. Chest 1996, 109:1243-1249.
20. Marston B.J., Plouffe J.F., File T.M., Hackman B.A., Salstrom S.J., Lipman H.B., Kolczak M.S., Breiman R.F. Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group. Arch. Intern. Med. 1997, 157:1709-1718.
21. Nagamine K., Watanabe K., Ohtsuka K., Hase T., Notomi T. Loop-mediated isothermal amplification reaction using a nondenatured template. Clin. Chem. 2001, 47:1742-1743.
22. Notomi T., Okayama H., Masubuchi H., Yonekawa T., Watanabe K., Amino N., Hase T. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res. 2000, 28:E63.
23. Parida M., Sannarangaiah S., Dash P.K., Rao P.V., Morita K. Loop mediated isothermal amplification (LAMP): a new generation of innovative gene amplification technique; perspectives in clinical diagnosis of infectious diseases. Rev. Med. Virol. 2008, 18:407-421.
24. Pedro-Botet M.L., Sabria-Leal M., Sopena N., Manterola J.M., Morera J., Blavia R., Padilla E., Matas L., Gimeno J.M. Role of immunosuppression in the evolution of Legionnaires' disease. Clin. Infect. Dis. 1998, 26:14-19.
25. Plouffe J.F., File T.M., Breiman R.F., Hackman B.A., Salstrom S.J., Marston B.J., Fields B.S. Reevaluation of the definition of Legionnaires' disease: use of the urinary antigen assay. Community Based Pneumonia Incidence Study Group. Clin. Infect. Dis. 1995, 20:1286-1291.
26. Roig J., Sabria M., Pedro-Botet M.L. Legionella spp.: community acquired and nosocomial infections. Curr. Opin. Infect. Dis. 2003, 16:145-151.
27. Salins S., Newton C., Widen R., Klein T.W., Friedman H. Differential induction of gamma interferon in Legionella pneumophila-infected macrophages from BALB/c and A/J mice. Infect. Immun. 2001, 69:3605-3610.
28. Skerrett S.J., Bagby G.J., Schmidt R.A., Nelson S. Antibody-mediated depletion of tumor necrosis factor-alpha impairs pulmonary host defenses to Legionella pneumophila. J. Infect. Dis. 1997, 176:1019-1028.
29. Swartz M.N. Clinical aspects of Legionnaires' disease. Ann. Intern. Med. 1979, 90:492-495.
30. Tan M.J., Tan J.S., File T.M. Legionnaires disease with bacteremic coinfection. Clin. Infect. Dis. 2002, 35:533-539.
31. Tateda K., Matsumoto T., Ishii Y., Furuya N., Ohno A., Miyazaki S., Yamaguchi K. Serum cytokines in patients with Legionella pneumonia: relative predominance of Th1-type cytokines. Clin. Diagn. Lab. Immunol. 1998, 5:401-403.
32. Tateda K., Deng J.C., Moore T.A., Newstead M.W., Paine R., Kobayashi N., Yamaguchi K., Standiford T.J. Hyperoxia mediates acute lung injury and increased lethality in murine Legionella pneumonia: the role of apoptosis. J. Immunol. 2003, 170:4209-4216.
33. Tkatch L.S., Kusne S., Irish W.D., Krystofiak S., Wing E. Epidemiology of Legionella pneumonia and factors associated with Legionella-related mortality at a tertiary care center. Clin. Infect. Dis. 1998, 27:1479-1486.
34. Waterer G.W., Baselski V.S., Wunderink R.G. Legionella and community-acquired pneumonia: a review of current diagnostic tests from a clinician's viewpoint. Am. J. Med. 2001, 110:41-48.
35. Yamamura M., Makimura K., Ota Y. Evaluation of a new rapid molecular diagnostic system for Plasmodium falciparum combined with DNA filter paper, loop-mediated isothermal amplification, and melting curve analysis. Jpn. J. Infect. Dis. 2009, 62:20-25.